These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 39389676)
1. EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner. Kim SH; Joshi K; Ezhilarasan R; Myers TR; Siu J; Gu C; Nakano-Okuno M; Taylor D; Minata M; Sulman EP; Lee J; Bhat KPL; Salcini AE; Nakano I Stem Cell Reports; 2024 Oct; 19(10):1516. PubMed ID: 39389676 [No Abstract] [Full Text] [Related]
2. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Kim SH; Joshi K; Ezhilarasan R; Myers TR; Siu J; Gu C; Nakano-Okuno M; Taylor D; Minata M; Sulman EP; Lee J; Bhat KP; Salcini AE; Nakano I Stem Cell Reports; 2015 Feb; 4(2):226-38. PubMed ID: 25601206 [TBL] [Abstract][Full Text] [Related]
3. MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma. Li B; Yan J; Phyu T; Fan S; Chung TH; Mustafa N; Lin B; Wang L; Eichhorn PJA; Goh BC; Ng SB; Kappei D; Chng WJ Blood; 2019 Dec; 134(23):2046-2058. PubMed ID: 31434700 [TBL] [Abstract][Full Text] [Related]
4. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation. Liu H; Sun Q; Sun Y; Zhang J; Yuan H; Pang S; Qi X; Wang H; Zhang M; Zhang H; Yu C; Gu C Mol Cancer Res; 2017 Sep; 15(9):1275-1286. PubMed ID: 28536141 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner. Gu C; Banasavadi-Siddegowda YK; Joshi K; Nakamura Y; Kurt H; Gupta S; Nakano I Stem Cells; 2013 May; 31(5):870-81. PubMed ID: 23339114 [TBL] [Abstract][Full Text] [Related]
7. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835 [TBL] [Abstract][Full Text] [Related]
8. TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway. Cai L; Liu Y; Li Y; Liu B; Cao Y; Yang W; Wang B; Sun T J Neurooncol; 2024 Sep; 169(2):269-279. PubMed ID: 38884661 [TBL] [Abstract][Full Text] [Related]
10. EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth. Corbin J; Yu X; Jin J; Cai L; Wang GG Oncogene; 2024 Aug; 43(36):2722-2736. PubMed ID: 39112519 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA TTBK2 promotes the development of human glioma cells via miR-520b/EZH2 axis. Yuan DH; Zhao J; Shao GF Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10886-10898. PubMed ID: 31858557 [TBL] [Abstract][Full Text] [Related]
12. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375 [TBL] [Abstract][Full Text] [Related]
13. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer. Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma. Cigliano A; Pilo MG; Mela M; Ribback S; Dombrowski F; Pes GM; Cossu A; Evert M; Calvisi DF; Utpatel K Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31861475 [No Abstract] [Full Text] [Related]
15. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence. Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis. Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105 [TBL] [Abstract][Full Text] [Related]
17. FOXM1-Dependent Transcriptional Regulation of EZH2 Induces Proliferation and Progression in Prostate Cancer. Tian JH; Mu LJ; Wang MY; Zeng J; Long QZ; Bin-Guan ; Wang W; Jiang YM; Bai XJ; Du YF Anticancer Agents Med Chem; 2021; 21(14):1835-1841. PubMed ID: 32735528 [TBL] [Abstract][Full Text] [Related]
18. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108 [TBL] [Abstract][Full Text] [Related]
19. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis. Cheng T; Xu Y Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602 [TBL] [Abstract][Full Text] [Related]